ADAMTS5
null ADAMTS5, or aggrecanase-2, is regarded as the dominant aggrecanase in articular cartilage, a conclusion drawn most convincingly from mice in which the catalytic activity of Adamts5 was ablated: these animals are strikingly protected from experimentally induced osteoarthritis. Like ADAMTS4 it cleaves aggrecan, versican and related hyalectans, and it is activated by furin-mediated removal of its prodomain. This in vivo primacy has made ADAMTS5 the preferred pharmacological target for cartilage preservation, and potent selective inhibitors are being developed, while recombinant ADAMTS5 supports aggrecanase activity assays. Beyond cartilage, ADAMTS5 also cleaves versican in the arterial wall and other matrices, connecting the enzyme to vascular remodeling as well.